Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05757154 Completed - Healthy Clinical Trials

Coffee for Optimal Metabolite Profile

Start date: March 31, 2023
Phase: N/A
Study type: Interventional

The aim of this project is to evaluate metabolite profile after consumption of three types of coffee differing in type of bean, degree of roasting and preparation method. Metabolite profiles will be evaluated after a) a single dose b) 3-day consumption. The study will be carried out as a three-way cross-over design with three different types of coffee. Wash-out periods where participants consume their habitual diet are implemented between all intervention periods. The first day of intervention (single dose) includes postprandial measurements during 13 hours.

NCT ID: NCT05756816 Completed - Healthy Clinical Trials

SurePulse Oximeter - a Targeted Oxygenation Observation

SPO-TOO
Start date: April 27, 2023
Phase: N/A
Study type: Interventional

This clinical investigation will investigate how accurate the SurePulse VS and SurePulse VS Patch (VSP) are for measuring blood oxygen levels (oxygen saturation). If the results are accurate, the VSP will be ready to apply for regulatory approval, meaning it could then be available for use on newborn babies in the National Health Service (NHS).

NCT ID: NCT05756673 Completed - Healthy Clinical Trials

A Study of Virtually Supervised Mouthwash and Interdental Brushes

Start date: February 9, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the relative effectiveness of oral (mouth) care regimens for the avoidance and treatment of plaque and gingivitis.

NCT ID: NCT05755191 Completed - Healthy Clinical Trials

A Study to Assess NEU-411 in Healthy Participants

Start date: May 22, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose (SAD), food effect (FE),multiple ascending dose (MAD), drug-drug interaction study, and bioavailability - bio-equivalence study of orally administered NEU-411 in healthy subjects

NCT ID: NCT05753033 Completed - Healthy Clinical Trials

The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers

Start date: February 28, 2023
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, placebo-controlled phase I PK bridging study to evaluate the PK, safety and tolerability of SR750 in healthy subjects.

NCT ID: NCT05750550 Completed - Healthy Clinical Trials

Acute Effect of Instrument-Assisted Soft Tissue Mobilization on Hamstring Flexibility Via Fascial Chain

Start date: March 30, 2023
Phase: N/A
Study type: Interventional

Instrument assisted soft tissue mobilization (IASTM) is one of the methods used to achieve fascial release. In this study, it will be examined whether there will be an increase in hamstring flexibility by releasing the superficial posterior fascial chain as a result of the IASTM technique to be applied over the triceps surae muscle and plantar fascia. Sociodemographic information of individuals who meet the inclusion criteria and volunteer to participate in the study will be obtained, and straight leg lift test and popliteal angle measurement will be performed with the digital inclinometer (Baseline Digital Inclinometer) to be provided within the scope of the project to measure hamstring flexibility. Then, IASTM will be applied to the triceps surae muscle and plantar fascia for 15 minutes. Measurements will be repeated after the application.

NCT ID: NCT05749848 Completed - Healthy Clinical Trials

A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants

Start date: February 24, 2023
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate how much of the study drug (LY3372689), administered as a single dose that has the radioactive substance 14C incorporated into it, passes from blood into urine, feces and expired air in healthy male participants. The study will also measure how much of the study drug gets into the bloodstream, how its broken down, and how long it takes the body to get rid of it. The study will last about 4 weeks. Screening is required within 28 days prior to the start of the study and follow up is required approximately 7 days after discharge.

NCT ID: NCT05749068 Completed - Healthy Clinical Trials

Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Evaluation of the CapScan intestinal collection device in characterizing the metabolism of sulfasalazine in the digestive tracts of healthy volunteers.

NCT ID: NCT05745701 Completed - Healthy Clinical Trials

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

Start date: February 22, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase 1, open-label, fixed-sequence, 3-period study to evaluate the effect of multiple doses of itraconazole and a single dose of cyclosporine on the single-dose PK of PF-07081532 in otherwise healthy, overweight or obese, adult female and male participants. The 3 study periods will be conducted consecutively without a break.

NCT ID: NCT05743647 Completed - Healthy Clinical Trials

Study of Cerebral Activation During Different Rehabilitation Tasks of Lower Limb in Virtual Mirror Therapy in Healthy Subjects

ARTHEMIRS2
Start date: February 20, 2023
Phase:
Study type: Observational

The purpose of this study is to investigate the cerebral activation during visual motor simulation in healthy subjects in 3 conditions: observation (OBS), observation and imagination (OBS-IM) and observation and realization (OBS-REAL). The investigators goal is to compare cerebral activation during the three different tasks using EEG and fNIRS.